135 related articles for article (PubMed ID: 27422212)
1. [Pharmaceutical intervention to reduce the iatrogenic risk associated with the triple whammy combination].
Arrufat-Goterris G; do Pazo-Oubiña F; Malpartida-Flores M; Rodríguez-Rincón RM
Aten Primaria; 2017 Mar; 49(3):150-155. PubMed ID: 27422212
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
Camin RM; Cols M; Chevarria JL; Osuna RG; Carreras M; Lisbona JM; Coderch J
Nefrologia; 2015; 35(2):197-206. PubMed ID: 26300514
[TBL] [Abstract][Full Text] [Related]
3. The Concomitant Use of Diuretics, Non-Steroidal Anti-Inflammatory Drugs, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (Triple Whammy), Extreme Heat, and In-Hospital Acute Kidney Injury in Older Medical Patients.
Mangoni AA; Kholmurodova F; Mayner L; Hakendorf P; Woodman RJ
Adv Ther; 2017 Nov; 34(11):2534-2541. PubMed ID: 29116624
[TBL] [Abstract][Full Text] [Related]
4. [Chronic Effects on Kidney Function by "Triple Whammy" (Combination of Renin and Angiotensin Type Inhibitor, Diuretic Drug and Nonsteroidal Anti-inflammatory Drug)].
Kunitsu Y; Isono T; Hira D; Terada T
Yakugaku Zasshi; 2019; 139(11):1457-1462. PubMed ID: 31685742
[TBL] [Abstract][Full Text] [Related]
5. Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.
Kunitsu Y; Hira D; Morikochi A; Ueda T; Isono T; Morita SY; Terada T
PLoS One; 2022; 17(2):e0263682. PubMed ID: 35139129
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of triple whammy acute kidney injury.
Prieto-García L; Pericacho M; Sancho-Martínez SM; Sánchez Á; Martínez-Salgado C; López-Novoa JM; López-Hernández FJ
Pharmacol Ther; 2016 Nov; 167():132-145. PubMed ID: 27490717
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in Japan.
Imai S; Momo K; Kashiwagi H; Miyai T; Sugawara M; Takekuma Y
Int J Clin Pharm; 2020 Oct; 42(5):1369-1373. PubMed ID: 32803559
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
[TBL] [Abstract][Full Text] [Related]
9. Rarely a triple whammy in general medicine.
Okamura-Kho A; Chuah Q; Chin P; Doogue M
N Z Med J; 2018 Jun; 131(1476):92-95. PubMed ID: 29879732
[No Abstract] [Full Text] [Related]
10. Drug Interactions Affecting Kidney Function: Beware of Health Threats from Triple Whammy.
Harężlak T; Religioni U; Szymański FM; Hering D; Barańska A; Neumann-Podczaska A; Allan M; Merks P
Adv Ther; 2022 Jan; 39(1):140-147. PubMed ID: 34845649
[TBL] [Abstract][Full Text] [Related]
11. Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control study.
Calvo DM; Saiz LC; Leache L; Celaya MC; Gutiérrez-Valencia M; Alonso A; Erviti J; Alzueta N; Echeverría A; Garjón J; Fontela C; Sanz L; Acín MT; Fernández ML; Gómez N
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):898-909. PubMed ID: 36960493
[TBL] [Abstract][Full Text] [Related]
12. NSAID use among residents in 68 residential aged care facilities 2014 to 2017: An analysis of duration, concomitant medication use, and high-risk conditions.
Lind KE; Raban MZ; Georgiou A; Westbrook JI
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1480-1488. PubMed ID: 31389118
[TBL] [Abstract][Full Text] [Related]
13. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis.
Whiting P; Morden A; Tomlinson LA; Caskey F; Blakeman T; Tomson C; Stone T; Richards A; Savović J; Horwood J
BMJ Open; 2017 Apr; 7(4):e012674. PubMed ID: 28389482
[TBL] [Abstract][Full Text] [Related]
14. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
Fournier JP; Lapeyre-Mestre M; Sommet A; Dupouy J; Poutrain JC; Montastruc JL
PLoS One; 2012; 7(3):e34187. PubMed ID: 22479557
[TBL] [Abstract][Full Text] [Related]
15. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Ren Fail; 2014 Aug; 36(7):1166-8. PubMed ID: 24826803
[TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury associated with "Triple whammy" combination: a protocol for a systematic review.
Calvo Barbado DM; Saiz Fernández LC; Leache Alegría L; Celaya Lecea MC; Gutiérrez-Valencia M
F1000Res; 2022; 11():496. PubMed ID: 36761833
[No Abstract] [Full Text] [Related]
17. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
Dreischulte T; Morales DR; Bell S; Guthrie B
Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
[TBL] [Abstract][Full Text] [Related]
18. 'Double Whamm' and 'Triple Whamm' combinations in hospitalized surgical patients - real life data from a tertiary teaching hospital.
Seiberth S; Berner J; Hug MJ; Strobach D
Pharmazie; 2022 Jan; 77(1):38-43. PubMed ID: 35045924
[TBL] [Abstract][Full Text] [Related]
19. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.
Lapi F; Azoulay L; Yin H; Nessim SJ; Suissa S
BMJ; 2013 Jan; 346():e8525. PubMed ID: 23299844
[TBL] [Abstract][Full Text] [Related]
20. The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol.
Morden A; Horwood J; Whiting P; Savovic J; Tomlinson L; Blakeman T; Tomson C; Richards A; Stone T; Caskey F
Syst Rev; 2015 Oct; 4():139. PubMed ID: 26497494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
